The Community Guide

- gsearch

Search Results

Narrow Results:

2023 2

GENDAAR Consortium 1

Journal Article 2

6-mercaptopurine 1
Autism spectrum disorder 1
Electroencephalography (EEG) 1
glutamine amidotransferase 1
malignant peripheral nerve sheath tumor 1
protide 1
Pubertal Maturation 1
Pubertal Timing 1
purine synthesis 1
Resting state 1
Spectral power 1
tumor metabolism 1

1 - 2 of 2 Results

Refine Results

Refine Results:

Pubertal maturation and timing effects on resting state electroencephalography in autistic and comparison youth

CITE Title : Pubertal maturation and timing effects on resting state electroencephalography in autistic and comparison youth Personal Author(s) : Rea, Hannah M.;Clawson, Ann;Hudac, Caitlin M.;Santhosh, Megha;Bernier, Raphael A.;Earl, Rachel K.;Pelphrey, Kevin A.;Webb, Sara Jane;Neuhaus, Emily; Corporate Authors(s) : GENDAAR Consortium Published Date : 11 2023;11-2023; Source : Dev Psychobiol. 65(7):e22415 URL : https://stacks.cdc.gov/view/cdc/148867 Rea, Hannah M. et al. (2023). Pubertal maturation and timing effects on resting state electroencephalography in autistic and comparison youth. 65(7). Rea, Hannah M. et al. "Pubertal maturation and timing effects on resting state electroencephalography in autistic and comparison youth" 65, no. 7 (2023) Rea, Hannah M. et al. "Pubertal maturation and timing effects on resting state electroencephalography in autistic and comparison youth" vol. 65, no. 7, 2023 Export RIS Citation Information.

:

Rea, Hannah M. ;

Clawson, Ann

11 2023 | Dev Psychobiol. 65(7):e22415

:

Autistic and comparison individuals differ in resting state encephalography (EEG), such that sex and age explain variability within and between groups...
Pro-905, a novel purine antimetabolite, combines with glutamine amidotransferase inhibition to suppress growth of malignant peripheral nerve sheath tumor

CITE Title : Pro-905, a novel purine antimetabolite, combines with glutamine amidotransferase inhibition to suppress growth of malignant peripheral nerve sheath tumor Personal Author(s) : Lemberg, Kathryn M.;Ali, Eunus S.;Krecmerova, Marcela;Aguilar, Joanna Marie H.;Alt, Jesse;Peters, Diane E.;Zhao, Liang;Wu, Ying;Nuha, Naziba;Asara, John M.;Staedtke, Verena;Pratilas, Christine A.;Majer, Pavel;Rais, Rana;Ben-Sahra, Issam;Slusher, Barbara S.; Published Date : 12 01 2023;12-01-; Source : Mol Cancer Ther. 22(12):1390-1403 URL : https://stacks.cdc.gov/view/cdc/148862 Lemberg, Kathryn M. et al. (2023). Pro-905, a novel purine antimetabolite, combines with glutamine amidotransferase inhibition to suppress growth of malignant peripheral nerve sheath tumor. 22(12). Lemberg, Kathryn M. et al. "Pro-905, a novel purine antimetabolite, combines with glutamine amidotransferase inhibition to suppress growth of malignant peripheral nerve sheath tumor" 22, no. 12 (2023) Lemberg, Kathryn M. et al. "Pro-905, a novel purine antimetabolite, combines with glutamine amidotransferase inhibition to suppress growth of malignant peripheral nerve sheath tumor" vol. 22, no. 12, 2023 Export RIS Citation Information.

:

Lemberg, Kathryn M. ;

Ali, Eunus S.

12 01 2023 | Mol Cancer Ther. 22(12):1390-1403

:

Malignant peripheral nerve sheath tumors (MPNST) are highly aggressive soft-tissue sarcomas that arise from neural tissues and carry a poor prognosis....